Literature DB >> 19958922

Personalized medicine: the future is not what it used to be.

Michael J Demeure1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19958922      PMCID： PMC2844719          DOI： 10.1016/j.surg.2009.10.023

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  28 in total

1.  Is anticancer drug development heading in the right direction?

Authors:  Trevor W Hambley; William N Hait
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

2.  Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

Authors:  M C King; S Wieand; K Hale; M Lee; T Walsh; K Owens; J Tait; L Ford; B K Dunn; J Costantino; L Wickerham; N Wolmark; B Fisher
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

3.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

Authors:  L C Hartmann; T A Sellers; D J Schaid; T S Frank; C L Soderberg; D L Sitta; M H Frost; C S Grant; J H Donohue; J E Woods; S K McDonnell; C W Vockley; A Deffenbaugh; F J Couch; R B Jenkins
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

5.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

Authors:  C T Brekelmans; C Seynaeve; C C Bartels; M M Tilanus-Linthorst; E J Meijers-Heijboer; C M Crepin; A A van Geel; M Menke; L C Verhoog; A van den Ouweland; I M Obdeijn; J G Klijn
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

7.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

Review 8.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

10.  Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Authors:  Timothy R Rebbeck; Tara Friebel; Henry T Lynch; Susan L Neuhausen; Laura van 't Veer; Judy E Garber; Gareth R Evans; Steven A Narod; Claudine Isaacs; Ellen Matloff; Mary B Daly; Olufunmilayo I Olopade; Barbara L Weber
Journal:  J Clin Oncol       Date:  2004-02-23       Impact factor: 44.544
View more
  3 in total

1.  Training of the endocrine surgical scientist.

Authors:  Janice L Pasieka
Journal:  Am J Transl Res       Date:  2010-02-15       Impact factor: 4.060

2.  Knowledge, Attitudes, and Practice Regarding Genetic Testing and Genetic Counselors in Jordan: A Population-Based Survey.

Authors:  Mamoun Ahram; Majd Soubani; Lana Abu Salem; Haneen Saker; Muayyad Ahmad
Journal:  J Genet Couns       Date:  2015-04-08       Impact factor: 2.537

3.  Translational research in retinology.

Authors:  Rubens Camargo Siqueira; Rodrigo Jorge
Journal:  Clin Ophthalmol       Date:  2011-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.